Beijing Tong Ren Tang Chinese Medicine Company Limited

SHSC:3613 Stock Report

Market Cap: HK$7.1b

Beijing Tong Ren Tang Chinese Medicine Balance Sheet Health

Financial Health criteria checks 5/6

Beijing Tong Ren Tang Chinese Medicine has a total shareholder equity of HK$4.0B and total debt of HK$249.0K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are HK$4.3B and HK$308.3M respectively. Beijing Tong Ren Tang Chinese Medicine's EBIT is HK$551.1M making its interest coverage ratio -7.6. It has cash and short-term investments of HK$1.8B.

Key information

0.006%

Debt to equity ratio

HK$249.00k

Debt

Interest coverage ratio-7.6x
CashHK$1.79b
EquityHK$3.97b
Total liabilitiesHK$308.26m
Total assetsHK$4.28b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 3613's short term assets (HK$3.7B) exceed its short term liabilities (HK$221.1M).

Long Term Liabilities: 3613's short term assets (HK$3.7B) exceed its long term liabilities (HK$87.2M).


Debt to Equity History and Analysis

Debt Level: 3613 has more cash than its total debt.

Reducing Debt: 3613's debt to equity ratio has reduced from 0.04% to 0.01% over the past 5 years.

Debt Coverage: 3613's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 3613 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 19:11
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Tong Ren Tang Chinese Medicine Company Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
null nullCMB International Securities Limited
Christina ChenHSBC